Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
Hui Xie,1,2 Jian-Fang Zhang,3 Qing Li2,4 1Department of Radiation Oncology, Affiliated Hospital (Clinical College) of Xiangnan University, Chenzhou, 423000, Hunan Province, People’s Republic of China; 2Key Laboratory of Medical Imaging and Artificial Intelligence of Hunan Province, Chenzhou, 423000,...
Enregistré dans:
Auteurs principaux: | Xie H, Zhang JF, Li Q |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bbd6f49b180e49e5b311b7222e6a8b44 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Development and Validation of a Novel Nomogram for Predicting Tumor-Distant-Metastasis in Patients with Early T1-2 Stage Lung Adenocarcinoma
par: Gu W, et autres
Publié: (2020) -
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
par: Guojun Lu, et autres
Publié: (2021) -
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
par: Xin Jin, et autres
Publié: (2021) -
Construction of competitive endogenous RNA network related to circular RNA and prognostic nomogram model in lung adenocarcinoma
par: Pingping Song, et autres
Publié: (2021) -
LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
par: Lin Z, et autres
Publié: (2021)